Virksomheder på COBIS

2N Pharmas mission er at bringe nye effektive terapier til patienter med ALS og andre neurodegenerative sygdomme.

Acesion Pharma is a Danish biotech company founded in 2011 by Morten Grunnet and Ulrik Sørensen and based on seeding capital from the venture funds Novo Seeds and SEED Capital Denmark. Acesion Pharma aims to develop more efficacious and safe drugs for the treatment of atrial fibrillation (AF), the most common type of cardiac arrhythmia. AF mainly affects the elderly population and often causes a pronounced decrease in quality of life and furthermore increases the risk of stroke. Existing drug therapies generally have a limited efficacy and/or are associated with risk of serious adverse events. Therefore, there is a considerable need for developing better and safer drugs. Inhibition of SK channels, an ion channel present in the heart and with relevance for the cardiac rhythm, constitute a novel and promising drug target for the treatment of AF. Acesion Pharma aims to develop a first-in-class SK channel inhibitor for the acute cardioversion of AF.

ADCendo ApS is a biotech company dedicated to developing new types of anti-cancer drugs. We focus on antibody-drug conjugates (ADCs) directed at novel targets, that have been found to be overexpressed by several cancer forms, that are all characterized by a significant unmet need for novel treatment.

Ankrin Therapeutics is a biotech start-up developing first-in-class drugs for cancer treatment. Our novel and unique therapeutic strategies, founded on forefront high quality research in cancer biology, target essential protein-protein interactions required for error-free DNA damage repair.

Our mission is to develop first-in-class peptide drugs for the treatment of dietary-related metabolic diseases.

A designer cell engineering and big data analysis platform to more rapidly generate safer and more efficacious cell therapies.

Avilex Pharma is developing novel inhibitors of PDZ domains to target a range of unmet medical needs.

Avineuro discovers and develops novel small molecules for unmet medical needs in neurology and psychiatry. Avineuro is managed by professionals experienced in drug discovery and development. By acquiring lead compounds through collaborations and partnerships, Avineuro develops novel products and extends the reach of marketed compounds for indications with a significant commercial potential. Avineuro emphasizes a rational approach that combines modern medicinal chemistry with streamlined pre-clinical and clinical development studies, thus allowing a fast transition to proof-of-concept product candidates.

Axxam S.p.A is an innovative Partner Research Organization (iPRO) providing science-driven, top quality and tailored Discovery Services.Axxam expertise includes:- Molecular biology: cloning and construct preparation, automated gene expression screenings (Taqman-based), protein expression, gene editing- Cell-line generation: GPCRs, ion channels, nuclear hormone receptors, transporters & others- Assay development: Biochemical assays (protein interactions & enzymes) and Cell-based assays including optogenetics biosensors- Natural and synthetic compound libraries- High-Throughput Screening automated platforms: fluorescence, luminescence & radiometric- High-Content Screening automated platforms- Compound management and Storage- Hit characterization & profiling- H2L activities, Cardiac safety and liability profiling- Electrophysiology (Manual & Automated Patch Clamping)With more than 16 years of experience, Axxam has successfully conducted hundreds of Hit identification projects, Hit-to-lead activities and Lead optimization programs.Axxam works with Clients globally and deals with projects from different market segments: Pharma, Biotech, Academia, Crop protection, Animal health, Cosmetics, Fragrances, Flavors and Nutrition.

BGI was founded in 1999 as a nonprofit research organization to support the Human Genome Project. Over the years, BGI has grown into a multi-national genomics company with significant global operations, including sequencing laboratories based in the US, Europe, Hong Kong and mainland China. BGI Europe’s headquarters were established in Copenhagen, Denmark, in 2010. Our experience in high-capacity, high- throughput analytics, bioinformatics capabilities, and our long history in large population–scale genomics and data analysis, means that BGI Europe is uniquely positioned to support both academic institutions and pharmaceutical companies with a wide array of high quality genomic services for basic research, pharmacogenomics and clinical diagnostics.

BioCare Copenhagen is a Danish bioscience company that specialises in microbial actives targeting gastrointestinal disorders, metabolism, infections and immunity. The company’s activities are based on research conducted by Copenhagen University Hospital, Denmark’s leading hospital for patients requiring highly specialised treatment. BioCare Copenhagen was established as a joint venture between the Danish Ministry for Science, Technology and Innovation and the management team Søren B. Thomsen (CEO) and Jesper Gantzel (COO). Offering innovative products with a strong competitive edge, BioCare Copenhagen and its partners have achieved a very robust market position on several European markets, including the Danish home market, reaching a market share of 70% in probiotic supplements. Furthermore, the company has been awarded with the Danish Gazelle price 2016 due to its continuously growth the previously four years.

The BioInnovation Institute offers entrepreneurs and researchers in life science help to bring interdisciplinary ideas to life and research to market. Through providing networks, support, facilities, and funding.BII embraces every phase of a life-science start-up company and though we are based in Denmark, our aspirations are international. BII is a Novo Nordisk Foundation initiative.

BioLib er en app store til biologisk data science. Vi tilbyder en zero-knowledge computation platform med apps fra forskere og firmaer. Vi udvikler infrastruktur som gør algoritmisk biologi tilgængeligt for alle.

Dedicated to develop novel stem cell therapies to treat chronic diseases

Providing 100% “Covid-19 SAFE” Spirometry services to patients.

CILcare er en unik CRO specialiseret i ørelidelser. Vi tilbyder prækliniske tjenester og rådgivning for at fremskynde udviklingen af ??innovative produkter til høretab, tinnitus og otiske lidelser.

Cirqle Biomedical develops a novel non-hormonal contraceptive for women based on the concept of mucus engineering

An independent consultancy company providing services within drug development. Focus areas:•Formulation, pre-formulation, characterization and comparability•Release specifications, in-use and shelf-life stability,•Peptides, proteins and novel drug concepts•Quality strategy and documentation: IND, IMPD, Quality overall•CRO and CMO management•Troubleshooting, root cause and risk assessment•Due diligence, ready for sales•Challenge and second opinion

Contera Pharma identifies and develops innovative treatments for patients suffering from movement disorders. We use our expertise in drug discovery and development in close collaboration with expert individuals and organizations to provide foundations for succes.

Copenhagen Life Science Advisors is a network of life science professionals with years of experience from pharmaceutical, biotech and medtech industries, as well as experience in working in and with life science venture capital. We work together as one, offering services in commercialization of science and fundraising of early stage companies.

Curasight is a clinical development company based in Copenhagen, Denmark. The Company is a pioneer in the field of exploiting a novel Positron Emissions Tomography (PET) imaging platform targeting the urokinase-type plasminogen activator receptor (“uPAR”). The technology provides improved diagnosis and risk stratification in multiple cancer types, most notably for risk stratification in prostate cancer.

Daiichi Sankyo and its 15.000 employees in more than 20 countries are dedicated to the creation and supply of innovative pharmaceutical products. In addition to a strong portfolio of medicines for hypertension and thrombotic disorders, the Group’s 2025 vision is to become a “Global Pharma Innovator with Competitive Advantage in Oncology”. Our European headquarters are in Munich, Germany and we have affiliates in 12 European countries. For more information: www.daiichi-sankyo.eu.

Dalux creates user friendly 2D and 3D visualization and configuration solutions to the building and production industry, especially within laboratories.

Mille International udvikler modermælkserstatninger og tilskudsblandinger primært til det kinesiske marked. Vi har fokus på innovation og er altid interesserede i interessant partnerskaber. Danish-Chinese Organic Food Center is aiming to facilitate and promote Danish organic food access and export to Chinese market as a third party platform

DANISH BIOTECH is a trade organization for Danish biotech companies with the aim to promote opportunities for biotechnology research, development and production in Denmark and perform common business interests in this context, both nationally and internationally. DANISH BIOTECH members are private companies in Denmark who research, develops or produces pharmaceuticals or other products with a significant content of biotechnology (biotech companies) and their parent companies and investment funds that are active owners of biotech companies. Membership can be obtained on www.danskbiotek.dk.

Defensin Therapeutics is a Danish biopharmaceutical company spun out from Novozymes A/S in 2013. Defensin Therapeutics focuses on the development and commercialization of novel products for the treatment of diseases and conditions associated with dysregulation of the human microbiota.

Develect is a small IP consultancy company, headed by Mrs. Mette Bergqvist. Develect provides patent solutions for start-ups

Domisphere ApS er et spin-off selskab fra iværksættervirksomheden INFUSER ApS, som er aktiv indenfor luftrensning og desinficering af overflader. Domisphere ApS udvikler og sælger patenterede løsninger til rensning af indendørsluft, baseret på fotoniske og katalytiske principper. Selskabets løsninger til luftrensning i indendørs miljøer er målrettet både BtB og BtC markedet på internationalt plan.

The aim of Ebumab is to develop biopharmaceuticals against rare disease.

The European Spallation Source (ESS) ERIC is a multi-national collaboration that is currently constructing the world’s brightest neutron scattering research facility in Lund, Sweden. The Data Management and Software Centre (DMSC), located in Copenhagen, Denmark, is an ESS Division that is responsible for developing the data acquisition, reduction, visualization and analysis software for the ESS neutron beam instruments, and for storing, and making available, the scientific research data taken at the ESS when it is operational.The ESS will be up to 100 times brighter than today’s leading neutron scattering facilities, enabling new opportunities for researchers in the fields of life sciences, energy, environmental technology, cultural heritage and fundamental physics.

Evaxion Biotech udvikler nye bioinformatik-baserede redskaber til af forudsige neoepitoper til personlig immunterapi rettet mod kræft og infektionssygdomme. Vi har etableret en robust produkt-skabende pipeline fra forudsigelse og optimering af de bedste neoepitoper , test i prekliniske modeller til klinikken.

Tal med lægen når og hvor det passer dig. Med Eyr tager du lægetiden på mobil – hurtigt, enkelt og sikkert.

Automatic insect mapping for sustainable agriculture.

Fischer BioConsult provides services relating to financing, business development and product development within the biotech sector. Per Fischer has more than 15 years experience from biotech, pharma and consulting, and has worked for more than 25 clients over a period of 4 years.

Intelligent surgical targeting - light up cancer and increase surgical precision.

Galecto develops small molecules for the treatment of severe diseases, including fibrosis and cancer. The company, founded in 2011, builds on more than 10 years of research centering on the role of galectin-3 and LOXL-2, and the use of modulators of these proteins to treat fibrosis-related diseases and cancer.

Genau & More operates in the regulated industries Pharma, Biotech, and Medical Device and are offering quality oriented consultancy within e.g. current compliance, validation, and business performance – services that will ensure the inspection readiness of the clients and ultimately help to ensure patient safety in medical treatment.

Hoba Therapeutics focuses on developing a disease-modifying treatment for neuropathic pain.

At HPNow, we believe that natural solutions are often the best. That is why we are introducing a novel technology solution for the on-site generation of a powerful, yet safe and eco-friendly water and air treatment agent. Our on-site generation devices produce pure hydrogen peroxide where and when it is needed using only water, air and electricity as input. These can be utilized in water treatment applications ranging from irrigation, livestock, aquaculture, municipal, residential, and through to chlorine-free swimming pool, as well as in air and surface treatment applications.

Hyamedix is a Hyaluronan technology company specialized in the development and use of various forms of Hyaluronan for the improvement and/or optimization in research, diagnostics, medical devices and drug delivery/release applications.

INFUSER is a unique air-purification company, pioneering novel clean-tech solutions that bridge the gap between science and industry. We specialize in merging private-public interests and shape scientific concepts based on atmospheric chemistry into leading-edge technologies, driven by strong international demand.

InProTher er en biotek virksomhed som udvikler aktiv immunterapi mhp. behandling af kræft

Inthera Bioscience is an emerging Swiss biotechnology company that develops innovative and highly effective therapies against currently incurable cancers. The company is tackling “undruggable” targets with innovative chemistry for the design of small molecule inhibitors of intracellular protein-protein interactions. The most advanced of these first-in-class therapeutics, a modulator of dysregulated transcription, is currently progressing towards clinical stage.

IO Biotech is a clinical stage biotech company developing disruptive immune therapies for immunological treatment of cancer. Our pipeline of first-in-class immune modulating anti-cancer therapies is based on a unique platform technology enabling the activation of T cells that are specific for immune inhibitory molecules.

ISD-Immunotech is developing a STING pathway modulator as a first-in-class treatment for Systemic Lupus Erythematosus (SLE) and other autoimmune diseases where the STING pathway is clearly shown to be implicated in the pathogenesis of the disease. ISD is a spin-out of Aarhus University and is run by a team of experienced pharmaceutical experts and business leaders with a solid track record of successful drug development.

IWA Consulting – For quality, safety, and efficacyThe IWA Consulting Team is a dedicated group of regulatory affairs specialists providing expert services to a range of international private and public clients. We do that based on our long term regulatory experience, in-depth knowledge, and expertise.We assist biotech, pharma, and medtech companies in achieving their major regulatory milestones, knowing and thoroughly understanding the sense of urgency that applies to this business area. Regulatory affairs – in every aspect of the discipline – is our core competence.Learn more about our services and how we work and feel free to contact us to discuss your specific needs regarding regulatory affairs.www.iwaconsulting.dk

Jusmedico is a specialist law firm providing legal services to the biotech, pharmaceutical, medical device, dentistry and veterinary industries, life science investors and to suppliers and service providers thereto. The working areas of Jusmedico include, without limitation, biotech start-ups, capital raising and re-funding activities, research & development, pre-clinical test (GLP) and clinical trial (GCP), manufacturing & supply (GMP), labeling & packaging, licensing, marketing alliances (co-promotion & co-marketing), agent and distribution agreements (GDP), advertising & promotion, pricing & reimbursement, parallel imports of pharmaceuticals and insurance issues related to all of said working areas, including product liability claims.Internationally, Jusmedico is a founding member of the BioLawEurope Alliance comprising a network of independent European law firms and individual attorneys providing legal services in the same fields as Jusmedico. Further, Jusmedico operates a representative office in New York, USA.Jusmedico is regulated by the Danish Bar and Law Society and is audited by Ernst & Young LLP, Copenhagen

Kariya Pharmaceuticals is developing first-in-class disease modifying agents to treat neurodegenerative diseases

KIBW Concept was founded in 2001 concentrating in GMP training and Audit activities. The company expanded in 2010 also to include activities such as CMC and Due Diligence, Quality Systems and QP duties.

LIFE SCIENCE PLUS Advokater provides specialized and business oriented legal advisory based upon more than 15 years of hands-on experience from the Life Science industry - both from an operational and strategic level.* General Legal Services - full spectrum of general commercial & R&D specific contracts, legal risk management, IP aspects as well as commercially oriented legal and strategic advice and compliance work.* Business Development/Licensing activities - coordination and structuring of licensing and other transactional activities, incl. due diligence processes, deal structures, drafting and negotiation as well as anchoring/integration.* Partnerships - structuring, drafting, negotiation and management of value creating partnerships & alliances with e.g. academia, institutions and commercial partners; R&D outsourcing and CRO vendor management.We also help companies to professionalize operations and governance to prepare them for external fundraising.

Linkberg blev stiftet i 2014 af Thomas K. L. Berggren. Thomas har adskillige års erfaring fra IT og analyse branchen. Linkberg foretager opsætning af spørgeundersøgelser, effektmåling af behandlingsforløb samt kundetilfredshedsundersøgelser for både offentlige og private virksomheder.

The LINX Association is the platform for Linking Industry to Neutrons and X-rays. LINX is the focal point for creating commercial value through innovative material science solutions based on advanced neutron & X-ray technology in collaboration with facilities, such as MAX IV, ESS and European XFEL.The LINX Association was established in spring 2016 to encompass “The LINX Project” funded by the Danish Innovation Fund (IFD) for a period of 5 years (2016-2021).

Medidee was established by three partners, all experts in the field of medical devices. As professionals with a multidisciplinary background we provide all necessary competences internally to handle all aspects of your project, from the Design to the Certification. Our team is expending regularly to provide the best resources and competences to address all dimensions of your project and to reach the ambitious milestones required by the marketing of your product. Hereafter are the key people of Medidee.

MEQU har opfundet en ny måde at varme IV-væsker op. Vi har skabt °M Varmeren- en præ-hospital iv væske/blood varmer til behandling af svært tilskadekomne patienter. Den varmer infusionsvæsker og blood op til en kropstemperatur for at forhindre/formindske hypotermi.

Minerva Imaging is a CRO specializing in molecular imaging services for accelerated and efficient drug development. Services offered are in vivo pre-clinical imaging assays, design and incorporation of imaging protocols in clinical trials, and consulting.

GBS is the leading cause of life-threatening bacterial infections in newborn babies affecting some 8,000 babies annually in Europe and the US. GBS infections may result in still-births, or pneumonia, septicaemia and meningitis in the newborn babies leading to either severe morbidity, mortality or life-long disabilites. MinervaX is pursuing the development of a novel vaccine candidate against Group B Streptococci (GBS).

Nex & Phister ApS (Law & IP) is focusing on providing strategic and legal counselling regarding IPR such as patents, trademarks, designs and copyright in the EU and internationally.

Nordetect er et analytisk hardwarefirma, der producerer Lab-on-a-chip enheder til miljø og jordanalyse med et stærkt fokus på præcisionslandbrug

Nordic Nanovector is a biopharmaceutical company dedicated to extending and improving the lives of patients with haematological cancers through the development and commercialisation of innovative targeted therapeutics.The company´s lead clinical-stage product is Betalutin®, the first in a new class of antibody radionuclide conjugates (ARCs), designed to improve upon and complement current options for the treatment of non-Hodgkin lymphoma (NHL). NHL is an indication with substantial unmet medical need and orphan drug opportunities.Betalutin® is a tumour-seeking anti-CD37 antibody conjugated to a low-intensity radionuclide (lutetium-177). It is showing promising efficacy and tolerability in a Phase 1/2 clinical study in a difficult-to-treat NHL patient population.The company aims to develop Betalutin® for the treatment of patients with relapsed/refractory NHL.Nordic Nanovector intends to retain marketing rights and to actively participate in the commercialisation of Betalutin® in core markets, while exploring potential distribution agreements in selected geographies.Nordic Nanovector is committed to building a pipeline of novel ARCs and antibody drug conjugates (ADCs) addressing multiple selected haematological malignancies based on proprietary technologies and expertise, and with technologies from partners where complementary.

nordisk family er en dansk virksomhed, der udvikler og markedsfører moderne vitamin- og kosttilskud.Virksomhedens produkter differentierer sig ved høj fødevarekvalitet, forbedret brugervenlighed, og en nem og bekvem købsoplevelse for deres kunder.

Orphazyme develops pharmaceuticals that target lysosomes. The company is dedicated to developing a novel class of therapeutics for the treatment of lysosomal storage diseases, a group of debilitating genetic disorders.

Ozack deliver value creating interactions with regulatory agencies during drug development.• prepare regulatory strategies to discover the best path and mitigate risk • explain ways of engaging regulators from early development and onwards• take you through the regulatory steps with execution of required documents and leadership if needed

Dedicated to improving life quality for millions of people suffering from diabetes, Pancryos is developing a next generation stem cell derived cell therapy PanINSULA™

Papermill Medical is a globally operating medical and scientific consultancy that provides services for companies and organizations in the life science industries including pharma, biotech and diagnostics. Based on a proven track record in R&D and commercial functions of the pharmaceutical industry Papermill Medical can support clients in different tasks such as:R&D strategy development and implementationNon-clinical pharmacologyScientific evaluation and value proposition development of early stage research opportunitiesProject managementPublication strategy development and implementationPreparation and editing of scientific and medical publications such as manuscripts, scientific and commercial presentations, registration files, market access value proposition and value dossiers

Patentgruppen rådgiver om IPR (Intellectual Property Rights), dvs. alt inden for patenter, brugsmodeller og designs. Patentgruppen ønsker at gøre det enkelt for dig at beskytte din forretning, produkter og innovation igennem en proaktiv og strategisk tilgang til IPR. Vi lader dig benytte alle vores tekniske og patentmæssige kompetencer ind i din virksomhed. Det bliver muligt, fordi vi arbejder i teams. Vi er både et team internt i Patentgruppen, men også et team med vores kunder. Uanset hvem du er og hvilke tekniske krav eller krav til IPR-viden, du har, så kan vi matche dit behov. Vi ser os selv som sparringspartner for vores kunder og vi er stolte over det arbejde, vi udfører.

Pharma IT leverer erfarne IT- og medicin udviklings konsulenter til pharma, biotech og medical device industrien.

PILA PHARMA is developing a novel type of oral anti-diabetic agent: a TRPV1 antagonist for the treatment of diabetes.

Red Glead Discovery is an established CRO company based in the south of Sweden in the research- intensive Medicon Valley region. Since its inception, the company has accumulated a large customer base both in Europe and overseas.

RefLab is a private Danish laboratory with extensive expertise in allergy and chronic urticaria testing, serving hospitals and allergy specialists. Further, we partner in projects within drug allergy and mechanisms of new anti-allergic drugs. In 2010 RefLab became a member of R-Biopharm group.

Centre for Innovation and Research (CIR) acts as a point of entry for issues relating to innovation and research and the commercialisation hereof in the Capital Region of Denmark. In addition to counselling and negotiating contracts, the centre actively leads projects to commercialise inventions and advises on clinical trials and funding. CIR also deals with strategic and political issues pertaining to innovation and research.

Reveal Consulting udarbejder og analyserer sundhedsdata og statistik, som gør det lettere for virksomheder og organisationer at træffe kvalificerede beslutninger, effektivisere deres processer og blive mere konkurrencedygtige.

The problem: Rheumatoid arthritis (RA) is a chronic debilitating disease with a high unmet medical need. Methotrexate (MTX) is the established cornerstone treatment of RA in all stages of the disease but has equally well-documented debilitating side effects which affects the vast majority of patients and in turn reduce MTX to a clinically viable treatment for a subsegment of RA patients, only.The solution: Targeted-MTX has promise to deliver the well understood clinical benefits of the established “cornerstone” treatment(MTX)for RA without the equally documented debilitating side-effects.The company: We have developed a targeted methotrexate (prodrug) that is designed for targeted release at the site of inflammation where high levels of ROS (reactive oxygen species) are present. MTX delivered as a proprietary molecule directly to the target with a game changing capability to disrupt and revolutionize the present treatment paradigm with a market potential of EUR 3.6 bn in RA in the US, EU and Japan.

LAB HOS is a company devoted to the design, develop and marketing of high-tech instruments for clinical testing and healthcare for labs and hospitals. We’re able to satisfy the exacting quality standards required by these industries thanks to the experience and expertise of our team. We are working in1. Lab section: we declare the best quality materials and high tech instrument to labs and IVO manufacturers, for example all reagents and instruments being used in immunoassay based clinical tests in medical and veterinary fields.2. Hospital section: we provide the EU approved facilities being used in patient caring like parts used in making bed hospital, different types of hospital and lab washing machines. Moreover, in clinical diagnostic section, we present PC based audiometers.

SELMA Diagnostics udvikler høj-sensitive molekylær diagnostiske test til tidlig detektion af kræftbiomarkører i blodbanen.

SoftOx Solutions AS is a Scandinavian medtech company, founded in 2012, after 4 years of research and product development.The SoftOx technology, using acetic acid together with the body’s own disinfector, is developed by SoftOx Solutions AS with the support of leading chemical scientists from CR Competence at University of Lund, Sweden. In 2016, SoftOx Solutions established a partnership with Professor Thomas Bjarnsholt, Chief Surgeon Klaus Kirketerp-Møller, and the University of Copenhagen.Scientists at University of Copenhagen have since 2007 conducted research on the use of acetic acid against biofilm, and since 2009 used acetic acid in clinical settings. The University of Copenhagen is a leading European research centre on biofilm and chronic wounds. SoftOx Solutions scientific department is established at the university under leadership of Thomas Bjarnsholt. Klaus Kirketerp-Møller will lead the company’s clinical research at Copenhagen University Hospital.

ANALYSIS SYSTEM FOR REAL-TIME MEASUREMENTSThe Spectro Inlets analysis system incorporates our unique microchip inlet technology with a vacuum and gas-handling system in conjuction with a mass spectrometer to deliver unprecedented real-time measurements of dissolved gases in liquid environments. The analysis system can characterize minute gas evolution at the surface of an electrode for electrochemistry and battery R&D. As the inlet is robust and self-cleaning, the system is also suitable for monitoring dissolved gases for industrial applications such as biogas production and wastewater treatment.

StatGroup provides statistical expertise for drug development covering early research to commercialization. For more than 10 years we have supported companies with short terms tasks as well as long term strategic collaboration.Just get in contact, and we will establish a legal framework (NDA) and arrange an informal scoping meeting.

STipe Therapeutics focuses on harnessing the innate immune system to battle cancer. The company has developed first-in-class drugs targeting intracellular protein-protein interactions of the STING Pathway; a major driver of innate immunity, and regulator of tumorigenesis and autoimmune disorders. The company has identified and validated compounds that sensitizes the STING pathway and by this modulates the tumor microenvironment to support a potent anti-tumoral response

Vi forhindrer kronisk stress og behandler dit stress med opmærksomhed.Personer under højt trykniveauer på arbejdspladsen er 45 procent mere tilbøjelige til at udvikle type 2-diabetes sammenlignet med dem, der oplever lavere stressniveauer. Ifølge WHO “Stress ville være den vigtigste kilde til sygdomme i 2020”. Vi løser # 1-problemet i vores samfund, og mens vi gør det, hjælper vi dem ved at være lykkelige.

Our aim is to eradicate the cytomegalovirus infection and provide long-term health benefits for transplant recipients.

• The Back Office tilbyder en fuld palette af ydelser inden for virksomhedsadministration og klassiske sekretæropgaver• Vi fungerer som din virksomheds Direktionsassistent, Management Support, HR-support, Office Manager eller traditionelle Salg/Marketingassistent• Med vores fleksible serviceydelser undgår du at ansætte en in-house sekretær eller administrativ medarbejder• Vi aflaster eller supplerer eksisterende medarbejdere• Den perfekte outsourcing-løsning til især entreprenører og startups, da vi har mange års erfaring fra innovationsmiljøerne på COBIS og Scion-DTU med administrativ assistance til især biotech, pharma, cleantech og IT-virksomheder

Trailhead er en biotekvirksomhed med speciale i teknologier, der optimerer differentiering af humane celler fra stamcellerTrailhead bruger avancerede eksperimenter og robotter med præcision til at differentiere menneskelige celler. Trailhead samarbejder med andre firmaer or organisationer med leverance af celler eller optimerende betingelser.

Union Medico is a Developer and Manufacturer of Injectable Drug Delivery Systems. We are a trusted partner and we have been working with some of the world’s leading Biotech and Pharma companies for years. Our injection system is out there worldwide, millions of injections are now carried out with this injection system.

VAR2 Pharmaceuticals is a privately held biotechnology company engaged in the design and development of proprietary therapeutic proteins targeting cancer-specific carbohydrate structures for multiple cancer indications. We have a portfolio of proteins with unique affinity and specificity for these cancer-associated carbohydrates for the development of treatments for cancers where there is no effective therapy, such as sarcoma, triple negative breast cancers and prostate cancer.The technology is based on groundbreaking discoveries made by researchers at University of Copenhagen, Denmark, in collaboration with partners at University of British Columbia, Canada.

Vild develops and markets safe, high quality products within children’s dermatology and supplements. Vild is pure and raw Nordic nature. We find raw materials and ingredients in the nature that surrounds us, and process them with an uncompromising attitude to quality and care. Simple and safe products for your child.

Scientific advice: In the area of pharmacology, toxicology and regulatory affairs - special focus on diabetes and veterinary medicine. Scientific reviews,safety/efficacy assessments, Drug development plans (screeningplans, CRO contact, project management with focus on translational medicine). Contract research: Pig glucose clamp model and general/ translational models for (diabetes) research in association with relevant CRO´s.

ZERION er et farmaceutisk udviklingsselskab, der forbedrer biotilgængeligheden af orale lægemidler ved at øge deres opløselighed. Med basis i den unikke Dispersome®? platformsteknologi, udvikler ZERION forbedrede lægemidler på tværs af alle terapiområder.